Sequential reduced-intensity chemotherapy for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia with rare cytogenetic abnormalities transformed from Fanconi anemia

Pediatr Int. 2018 Sep;60(9):893-894. doi: 10.1111/ped.13648.
No abstract available

Keywords: RUNX1-CBFA2T3; Fanconi anemia; acute myeloid leukemia; allogeneic stem cell transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chromosome Aberrations
  • Cytarabine / therapeutic use
  • Fanconi Anemia / complications*
  • Fanconi Anemia / therapy
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Transplantation Conditioning / methods*
  • Transplantation, Homologous / methods
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use

Substances

  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Vidarabine

Supplementary concepts

  • FLAG protocol